GlassScriptPhysician profile
Shaun C Corbett
NPI 1124269824
$419.59
in general payments reported to CMS, 2019-2025
13 companies · $31.32 in 2025
The $31.32 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $31.38 · 2021: $123 · 2023: $69.79 · 2024: $52.83 · 2025: $31.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $112.84 | 2019-2023 | Trulicity |
| Astrazeneca Pharmaceuticals LP | $62.15 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $38.59 | 2023-2024 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $31.32 | 2025 | Austedo Xr |
| Avanir Pharmaceuticals, INC. | $29.26 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $27.18 | 2019 | |
| Neurocrine Biosciences, INC. | $24.96 | 2024 | Ingrezza |
| Kci USA, INC. | $18.45 | 2023 | Activ.A.C. |
| Janssen Pharmaceuticals, INC | $18.04 | 2019 | |
| Acadia Pharmaceuticals INC | $15.42 | 2019 | |
| Qiagen, LLC | $14.63 | 2019 | |
| Xeris Pharmaceuticals, INC. | $14.42 | 2024 | Gvoke Hypopen |
| Osiris Therapeutics INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Corbett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.